Steep Hill Opens Cannabis Testing and Analytics Lab In Albuquerque, New Mexico
"Since New Mexico's passage of medical cannabis regulations in 2007, the state's medical cannabis market has become highly accessible to patients. The regulatory requirements being implemented by New Mexico are of the highest caliber and now assure that patients can access safe, tested, and efficacious medicinal cannabis products,” Steep Hill CEO David Lampach said, “This is a real breakthrough for New Mexico that other states will draw inspiration from as they consider regulation in the future."
According to the firm, “Steep Hill is working with regulators to move from provisional approval to a fully operational license over the next several weeks for the various analyses required by the State. Steep Hill is using state-of-the-art testing equipment at its Albuquerque lab to screen medical cannabis for various active components as well as potentially harmful micro-biological contaminants.”
Steep Hill's equipment is validated by international accrediting organizations and by Steep Hill's internal experts, company officials said. Over the next several months, the lab will add residual solvent and mycotoxin screening as required under NMAC 7.34, with other toxin screens coming, as well.
2018 Leading Metro Locations: Pacific and Mountain Metros Dominate the List
33rd Annual Corporate Survey & the 15th Annual Consultants Survey
2018 Top States for Doing Business: Georgia Ranks #1 Fifth Year in a Row
Made in America: An Outlook for Manufacturing in the U.S.
Location USA 2018
A Changing Food Manufacturing Industry
2017 Food Processing
Opportunity Zones Can Uplift Communities and Investors Alike